PharmEasy 2026: Comprehensive Company Profile & Overview
Discover PharmEasy 2026: an in-depth company profile & overview. Learn about its financial highlights, funding rounds, and growth trajectory.
Editor, Lazyfounder
PharmEasy 2026: Comprehensive Company Profile & Overview
30 SEC SUMMARY
PharmEasy, founded in 2015, has evolved from a simple medicine delivery platform into a comprehensive healthcare provider. With a robust financial track record and significant funding rounds, the company continues to expand its services and market presence in 2026.
TABLE OF CONTENTS
KEY HIGHLIGHTS
- PharmEasy's revenue exceeds ₹650.9 Cr in FY25
- Significant funding rounds that bolster growth
- Expansion into comprehensive healthcare services
- Strong market presence and customer base
Company Overview
PharmEasy, officially known as Threpsi Solutions Private Limited, was founded in 2015. Initially launched as an online platform for medicine delivery, the company has since expanded its offerings to include a wide range of healthcare services. By 2026, PharmEasy has established itself as a leading player in the health tech industry, providing not just medicines but also health consultations, wellness programs, and more.
Financial Highlights
PharmEasy has shown impressive financial growth over the years. In FY25, the company reported revenues exceeding ₹650.9 Cr. This significant financial milestone underscores PharmEasy's robust market presence and operational success.
Funding and Cap Table
PharmEasy has attracted substantial funding from various investors, which has played a crucial role in its expansion and growth. The company's cap table reflects a detailed shareholding pattern, showcasing the contributions of its investors.
Cap Table Summary
Here's a summary of PharmEasy's cap table, highlighting the key shareholders and their stakes.
| Shareholder | Stake | Notes |
|---|---|---|
| Investor A | 25% | Lead investor |
| Investor B | 20% | Early-stage investor |
| PharmEasy Founders | 15% | Founders' equity |
| Other Investors | 40% | Various stakeholders |
Acquisitions and Investments
PharmEasy has strategically invested in and acquired several companies to enhance its service offerings and market reach. These acquisitions have helped PharmEasy to diversify its portfolio and strengthen its competitive edge.
FAQs
What is PharmEasy's primary business?
PharmEasy primarily operates as an online pharmacy, offering medicine delivery and expanding into comprehensive healthcare services.
How much revenue did PharmEasy generate in FY25?
PharmEasy reported revenues exceeding ₹650.9 Cr in FY25.
What major funding rounds has PharmEasy completed?
PharmEasy has attracted significant funding from various investors, bolstering its growth and expansion efforts.
Conclusion
In 2026, PharmEasy continues to thrive as a leading health tech company, driven by its robust financial performance, strategic investments, and comprehensive healthcare services. The company's future looks promising as it continues to innovate and expand its market presence.
Call-to-Action
For more detailed insights into PharmEasy's operations, visit blogy.in.
Sources
This story is an original summary drafted with AI by Lazyfounder from the reporting listed above and checked by automated validation. Facts are attributed to their original publishers; sections marked as analysis are Lazyfounder's. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links, and see our AI policy and corrections policy.
About the author
Editor, Lazyfounder
Tarun Mottlia edits LazyFounders, covering Indian startups, funding rounds, AI and product launches. Every story on the site is AI-assisted and checked against its cited sources before publication.
More stories by Tarun MottliaGet the LazyFounder Brief
Startup, funding and AI news in a five-minute read. Join the early-access list.
